Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT00367393
Eligibility Criteria:
Inclusion Criteria:
* clinically diagnosed AD
* almost clear to mild AD (local IGA \[target lesions face and cubital areas\] score of 1-3)
* clinically (i.e. to the unaided eye) evident skin atrophy due to long-term topical steroid use
* Dermatophot Score (DPS - composed of skin atrophy and telangiectasia) of 4-6 on at least two target areas
Exclusion Criteria:
* Phototherapy or systemic therapy known or suspected to have an effect on AD within 4 weeks prior to study entry
* Topical therapy known or suspected to have an effect on AD within 7 days prior to study entry or systemic corticosteroids within 4 weeks prior to study entry
* Clinical conditions other than AD that according to investigator can interfere with the Dermatophot evaluation
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00367393
Study Brief:
Protocol Section:
NCT00367393